Skip to content

A Trial on the Use of Point-of-care Ultrasound in the Assessment of Breast Symptoms

Breast Point-of-Care Ultrasound Examination Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06932133
Acronym
Breast-POCET
Enrollment
600
Registered
2025-04-17
Start date
2025-04-07
Completion date
2027-02-12
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

artificial intelligence, point-of-care ultrasound

Brief summary

The high cost of diagnostic equipment, limited expertise, and inadequate infrastructure are major barriers to early breast cancer diagnosis in low- and middle-income countries. Point-of-care ultrasound (POCUS) offers a relatively low-cost, portable solution that, when combined with artificial intelligence (AI)-driven image analysis, has the potential to significantly expand access to breast assessment in these settings. The purpose of this study is to evaluate the performance of POCUS for women with focal breast symptoms and to assess the performance of AI to analyze POCUS images. The study will be divided in two parts: a prospective interventional study and a retrospective multicase multireader study.

Detailed description

In this trial we want to understand if the use of POCUS is non-inferior to Standard of Care (SoC) and if the combination of POCUS AI can reach non-inferior performance to that of breast radiologists. There is a need for breast diagnostic tools in underserved countries since late-stage diagnosis is a major cause of the high breast-cancer mortality in low-and middle-income countries. Showing that POCUS can be sufficient for an assessment of focal breast symptoms can provide evidence for a broader use. Also, enabling automated interpretation using AI can add to the value of this low-cost and accessible solution. The first part of the trial is a prospective open-label accuracy study with paired design. The intervention of POCUS as a targeted diagnostic method for women with focal breast complaints will be compared with SoC. We will also be able to compare POCUS with the individual components of SoC (mammography and standard ultrasound) and retrospectively with POCUS AI. The second part of the trial is a single-blinded retrospective paired mulitcase multireader study. In this part we can directly assess POCUS and POCUS AI without the influence of mammography and benchmark to a larger group of radiologists and in addition compare with standard ultrasound

Interventions

DIAGNOSTIC_TESTPoint-of-care ultrasound

Point-of-care ultrasound will be performed on symptomatic breast patients. The images will be analysed by AI

Sponsors

Region Skane
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women (≥18 years of age) referred to diagnostic imaging with a suspicion on malignancy

Exclusion criteria

* Individuals unable to comprehend the study information due to language barriers or cognitive impairments.

Design outcomes

Primary

MeasureTime frameDescription
The area under the receiver operating characteristic curve (AUC) for the intervention, compared to that of the comparatorFrom the last enrolled participant to the end of one-year follow up1. The AUC of POCUS compared to SoC 2. The AUC of AI compared to average radiologists on POCUS

Secondary

MeasureTime frameDescription
The performance of POCUS and POCUS AIFrom the last enrolled participants to the end of one year follow up* The sensitivity, specificity, PPV, and NPV of POCUS compared to SoC (Part 1) * The sensitivity, specificity, PPV, and NPV of POCUS compared to standard ultrasound (Part 1) * The sensitivity, specificity, PPV, and NPV of POCUS compared to mammography (Part 1) * The AUC of POCUS AI compared to SoC (Part 1) * The AUC, sensitivity, and specificity of POCUS in relation to tumor type, stage, breast density, previous history of breast cancer, age, and demographics (Part 1 and Part 2) * The AUC, sensitivity and specificity of POCUS AI in relation to tumor type, stage, breast density, previous history of breast cancer, age, and demographics (Part 1 and Part 2) * The sensitivity, specificity, PPV, and NPV of average radiologists on POCUS compared to standard ultrasound (Part 2) * The sensitivity and specificity of POCUS AI at different operating thresholds (Part 2) * The balanced accuracy of POCUS AI compared to average radiologists (Part 2) * The AUC, sensitivity, and specificity of POCUS AI

Countries

Sweden

Contacts

PRINCIPAL_INVESTIGATORKristina Lång, MD PhD

Lund University, Unilabs Mammography

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026